India’s Largest Omnichannel Eyewear Platform is Going Public
Growth. Margins. Premium Valuation. Is Clarity in Sight?
Type: Book-built issue (Fresh + OFS)
Total Issue Size: ₹7,278 Cr (Fresh: ₹2,150 Cr + OFS: ₹5,128 Cr)
Market Cap (Upper Band): Estimate post listing
Employee/Anchor Quota: Yes; ₹19/share employee discount, anchor investors already allocated.
Minimum Investment (Retail): ₹14,874 (1 lot at ₹402)
Investment Call: Listing gains likely; long-term suitable for high-growth, risk-tolerant portfolios.
Time Horizon View: 12–24 months for core business and margin trend realization. Investors investing with a timeframe of less than 10 years are at risk as companies need time to grow big.
Star Rating: ★★★★☆ (3.5/5)
One-Line Thesis: Lenskart combines category leadership, omnichannel reach, rapid growth, and a positive profit swing – but commands a hefty valuation premium.
Bull Case:
Scale and network effect in a massive, underpenetrated market
Margin inflection and profits from FY25 onwards
Strong operational execution and tech advantage
Key Risks:
Expensive price-to-earnings; modest ROE, ROCE
Large OFS supply; competitive intensity
Scaling execution, working capital management
Lenskart operates an integrated digital+offline platform focused on prescription glasses, sunglasses, and lenses. Their business spans from design, technology, and manufacturing, to retailing via stores (India’s largest chain) and robust online channels.
Revenue Mix: Predominantly prescription eyewear; some sunglasses, contact lenses.
Geography: Majority in India; growing international operations.
Moat: Tech-driven, supply chain, proprietary products, superior customer experience.
*FY25: Projected; 1QFY26 (PAT margin 4.2%+) points to margin expansion.
Growth Capex & Network Expansion: Major portion
Tech/Innovation/Working Capital: Next largest
Employee quota, others: Smaller allocations
🟡 Best Company for long term:
Titan with a diversified portfolio of growing and mature products with leading in many segments and a debt free status. Yes, Titan could be given 5 Star rating v/s 3.5 to LensKart.
🟡 Expensive:
Premium is not fully justified. Lenskart needs to sustain high growth/margins, but risk exists if returns lag.
Execution risk—rapid scale-up needed
Competition (domestic/global/online/offline)
Returns still lag trailing multiples
Heavy OFS (supply overhang possibility)
FY26 Revenue: ₹8,100–8,800 Cr
PAT: ₹370–₹450 Cr (if margin profile holds)
F_EPS: 2 Then also at an offered price of 402 the F-PE comes 201X which is high.
For retail: Staggered buys post-listing dips
Aggressive: Go at IPO, partial booking if >15% gain on debut, but be cash rich due to high valuations.
Avoid if: Margins/ROE stall or market weakens sharply
Do remember that Titan offers the better Risk adjusted return.
Lenskart IPO offers the rare mix of scale, tech, and brand in a nascent market. Just be mindful: Growth is in focus, but earnings-based valuation remains demanding. Best for high-conviction, high-risk appetite investors only.
In IPOs and eyewear, clear vision is priceless—but don’t expect 20/20 profits right away!
Ready to Level Up?
Join our investor learning workgroup for exclusive IPO teardowns, live analysis, and wealth-building masterclasses. Next session: “RHP to Real Portfolio—How to Pick Winners!”
Welcome, there!
Your account is active. Enjoy full access.